Biostatisticians identify genes linked to heart disease

February 6, 2013, University of Massachusetts Amherst

Recently, large studies have identified some of the genetic basis for important common diseases such as heart disease and diabetes, but most of the genetic contribution to them remains undiscovered. Now researchers at the University of Massachusetts Amherst led by biostatistician Andrea Foulkes have applied sophisticated statistical tools to existing large databases to reveal substantial new information about genes that cause such conditions as high cholesterol linked to heart disease.

Foulkes says, "This new approach to data analysis provides opportunities for developing new treatments. It also advances approaches to identifying people at greatest risk for heart disease. Another important point is that our method is straightforward to use with freely available computer software and can be applied broadly to advance genetic knowledge of many diseases. We hope this moves us toward greater understanding of common disorders and improving overall health in our society."

The new analytical approach she developed with cardiologist Dr. Muredach Reilly at the University of Pennsylvania and others is called "Mixed modeling of P-values" or MixMAP. Because it makes use of existing public databases, the powerful new method represents a low-cost tool for investigators.

Foulkes, who directs the Institute for , and Bioinformatics at UMass Amherst, explains that MixMAP draws on a principled statistical modeling framework and the vast array of summary data now available from genetic association studies to formally test at a new, locus-level, association. Other members of the team at UMass Amherst are Rongheng Lin, an assistant professor, and postdoctoral researchers Gregory Matthews and Ujwall Das.

The new method, which is generalizable to other problems, takes into account the structure of the genome, Foulkes explains. In genetic epidemiology, traditional genome-wide association studies look at common genetic variations in a group of people with a disease compared to healthy controls, focusing on single-nucleotide polymorphisms (SNP) to see if any single variant is associated with that disease. If one variant is found more often in people with the disease, the SNP is thought to be associated with it.

While that traditional statistical method looks for one unusual "needle in a haystack" as a possible disease signal, Foulkes and colleagues' new method uses knowledge of DNA regions in the genome that are likely to contain several genetic signals for disease variation clumped together in one region. Thus, it is able to detect groups of unusual variants rather than just single SNPs, offering a way to "call out" gene regions that have a consistent signal above normal variation.

Foulkes offers a non-technical analogy, "It's like listening to an orchestra. If there is one drum, we all hear it, and we hear the cello section even if each instrument is playing quietly, because they are all playing together. Current statistical methods can hear the drum, but not the cellos, no matter how many are playing, because no single cello is as loud as the drum. Our method can do this, which adds considerable statistical strength to our ability to identify new genes that may be associated with disease."

Reilly points out that as a complementary strategy to traditional methods, MixMAP will be of great interest to the statistical and cardiovascular genomics community. It can be applied to existing genetic studies of blood cholesterol levels and it already suggests a dozen new genes to explore further for an important risk factor: Low density lipoprotein cholesterol.

Foulkes characterizes the new technique as discovery science still in need of validation, but it's discovery science that goes farther than usual by using sophisticated modeling approaches to quantify error. "We've done better than simply identify the strongest signals, we've quantified measures of association to show they are statistically meaningful," she points out.

Overall, the authors say, "MixMAP offers new and complementary information as compared to single nucleotide polymorphism-based analysis approaches and is straightforward to implement with existing open-source statistical software tools."

The research is published today in Plos One.

Explore further: New statistical method could improve search for genes involved in common diseases

Related Stories

New statistical method could improve search for genes involved in common diseases

May 17, 2011
Recent breakthroughs in the analysis of genetic variation in large populations have led to the discovery of hundreds of genes involved in dozens of common diseases. Many of these discoveries were enabled by performing "meta-analysis," ...

New approach for efficient analysis of emerging genetic data

September 6, 2012
(Medical Xpress)—With the ability to sequence human genes comes an onslaught of raw material about the genetic characteristics that distinguish us, and wading through these reserves of data poses a major challenge for life ...

A hidden architecture: Researchers use novel methods to uncover gene mutations for common diseases

March 25, 2012
Human geneticists have long debated whether the genetic risk of the most common medical conditions derive from many rare mutations, each conferring a high degree of risk in different people, or common differences throughout ...

More links found between schizophrenia, cardiovascular disease

January 31, 2013
A new study, to be published in the Feb. 7, 2013 issue of the American Journal of Human Genetics, expands and deepens the biological and genetic links between cardiovascular disease and schizophrenia. Cardiovascular disease ...

Recommended for you

Can mice really mirror humans when it comes to cancer?

January 18, 2018
A new Michigan State University study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer.

Two new breast cancer genes emerge from Lynch syndrome gene study

January 18, 2018
Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes—MSH6 and PMS2—approximately doubles a woman's risk of developing breast ...

Peers' genes may help friends stay in school, new study finds

January 18, 2018
While there's scientific evidence to suggest that your genes have something to do with how far you'll go in school, new research by a team from Stanford and elsewhere says the DNA of your classmates also plays a role.

A centuries-old math equation used to solve a modern-day genetics challenge

January 18, 2018
Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.

Epigenetics study helps focus search for autism risk factors

January 16, 2018
Scientists have long tried to pin down the causes of autism spectrum disorder. Recent studies have expanded the search for genetic links from identifying genes toward epigenetics, the study of factors that control gene expression ...

Group recreates DNA of man who died in 1827 despite having no body to work with

January 16, 2018
An international team of researchers led by a group with deCODE Genetics, a biopharmaceutical company in Iceland, has partly recreated the DNA of a man who died in 1827, despite having no body to take tissue samples from. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.